Table I.
Case reports of PTX as a complication of BV.
| Case report, year | Patient no. | Age (years)/sex | Cancer type | Disease on the side of the PTX | Chemotherapy | No. of preceding cycles (days since last cycle) | Management | (Refs.) |
|---|---|---|---|---|---|---|---|---|
| Zhang et al, 2012 | 1 | 23/M | Fibrosarcoma | No | BV + DP | 3 | Small-caliber chest tube | (6) |
| Yang et al, 2011 | 1 | 45/M | CRC | Yes | BV + FOLFOXIRI | 2 | Small-caliber chest tube | (7) |
| Koh et al, 2013 | 1 | 54/M | NSCLC | Unknown | BV + carboplatin + paclitaxel | Unknown | Conservative management | (9) |
| Iida et al, 2016 | 1 | 57/M | CRC | Yes | BV + XELOX followed by BV + FOLFIRI | 8 of first regimen and 5 of second regimen | Chest drainage with aspiration followed by pleurodesis with blood 4 weeks later followed by surgery | (10) |
| Bazan et al, 2014 | 1 | 38/M | Synovial sarcoma | Yes | BV + temozolomide | 3 | Conservative management | (11) |
| Ueda et al, 2015 | 1 | 56/F | Breast cancer | Yes | BV + paclitaxel | NA | Endobronchial Watanabe spigot | (12) |
PTX, pneumothorax; BV, bevacizumab; CRC, colorectal carcinoma; DP, docetaxel, cisplatin; M, male; F, female; NRSTS, non-rhabdomyosarcoma soft tissue sarcoma; NSCLC, non-small-cell lung carcinoma; RCC, renal cell carcinoma; VATS, video-assisted thoracoscopic surgery; FOLFOXIRI: Folinic acid + 5-fluorouracil + oxaliplatin + irinotecan; XELOX, capecitabine + oxaliplatin; FOLFIRI, folinic acid + 5-fluorouracil + irinotecan.